Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global formulation development outsourcing market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.

Formulation Development Outsourcing Market Trends:

The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer’s disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on service, dosage form, application and end user.

Breakup by Service:

  • Pre-formulation Services
    • Discovery and Preclinical Services
    • Analytical Services
  • Formulation Optimization
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
       

Breakup by Dosage Form:

  • Injectable
  • Oral
  • Topical
  • Others
     

Breakup by Application:

  • Oncology
  • Genetic Disorders
  • Neurology
  • Infectious Diseases
  • Respiratory
  • Cardiovascular
  • Others
     

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Government and Academic Institutes
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Service, Dosage Form, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global formulation development outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global formulation development outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Formulation Development Outsourcing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Service
    6.1    Pre-formulation Services
        6.1.1 Market Trends
       6.1.2 Key Segments
           6.1.2.1 Discovery and Preclinical Services
           6.1.2.2 Analytical Services
        6.1.3 Market Forecast
    6.2    Formulation Optimization
        6.2.1 Market Trends
       6.2.2 Key Segments
           6.2.2.1 Phase I
           6.2.2.2 Phase II
           6.2.2.3 Phase III
           6.2.2.4 Phase IV
        6.2.3 Market Forecast
7    Market Breakup by Dosage Form
    7.1    Injectable
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Oral
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Topical
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Application
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Genetic Disorders
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Neurology
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Infectious Diseases
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Respiratory
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Cardiovascular
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by End User
    9.1    Pharmaceutical and Biopharmaceutical Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Government and Academic Institutes
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Aizant Drug Research Solutions Private Limited
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Catalent Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Charles River Laboratories
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Dr. Reddy’s Laboratories Ltd.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Emergent BioSolutions Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Intertek Group plc
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Irisys LLC (Recro Pharma)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Laboratory Corporation of America Holdings
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Lonza Group AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Piramal Pharma Solutions
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
        15.3.11    Quotient Sciences
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
        15.3.12    Syngene International Limited (Biocon Limited)
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
        15.3.13    Thermo Fisher Scientific Inc.
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2020
Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2020
Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2020
Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2020
Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2020
Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2020
Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2021-2026
Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2021-2026
Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
Table 8: Global: Formulation Development Outsourcing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links